Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.4%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
- Check41 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe page has removed an erratum related to the safety profile of upadacitinib in rheumatoid arthritis, which may affect the accuracy of the information presented.SummaryDifference0.2%
Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.